Does Muscle-Derived Interleukin-6 Mediate Some of the Beneficial Effects of Exercise on Cancer Treatment-Related Fatigue?
Authors:
- Lisa J. WoodLWLisa J. Wood
- Lillian M. NailLNLillian M. Nail
- Kerri A. WintersKWKerri A. Winters
- 1 September 2009
- journal article
- Published by Oncology Nursing Society (ONS) in Oncology Nursing Forum
- Vol. 36 (5) , 519-524
Abstract
To review evidence that muscle-derived interleukin-6 (IL-6) mediates some of the beneficial effects of exercise on cancer treatment-related fatigue (CTRF). Electronic nursing, psychology, and medicine databases. Fatigue is a common and often debilitating symptom associated with cancer treatment. Although the molecular mechanisms underlying CTRF have yet to be fully elucidated, it may be akin to the fatigue associated with "sickness behavior," which is initiated by the production of the proinflammatory cytokines interleukin-1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF-alpha). Physical exercise has been shown to decrease fatigue levels in patients with cancer undergoing treatment. Skeletal muscle selectively produces IL-6 during exercise, and muscle-derived IL-6 can decrease the production and activity of IL-1 beta and TNF-alpha. Thus, the anti-inflammatory effects of muscle-derived IL-6 may be a mechanism underlying the observed beneficial effects of exercise on CTRF. Further studies are needed to determine whether the anti-inflammatory effects of exercise underlie its beneficial effects on CTRF. Nurses have proven to be leaders in the field of cancer symptom management. An understanding of potential mechanisms underlying the beneficial effects of exercise on CTRF may help to fine-tune exercise interventions to maximize symptom control and to identify new treatment strategies for fatigued patients with cancer who are unable to participate in an exercise program.Keywords
This publication has 49 references indexed in Scilit:
- The Role of Inflammation in Vascular Insulin Resistance with Focus on IL-6Hormone and Metabolic Research, 2008
- Inhibition of p38 MAPK Suppresses Inflammatory Cytokine Induction by Etoposide, 5-Fluorouracil, and Doxorubicin without Affecting Tumoricidal ActivityPLOS ONE, 2008
- Twenty years of research on cytokine-induced sickness behaviorBrain, Behavior, and Immunity, 2007
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman diseaseBlood, 2005
- Inflammatory processes in muscle injury and repairAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Exercise normalises overexpression of TNF-α in knockout miceBiochemical and Biophysical Research Communications, 2004
- Transcriptional activation of the IL‐6 gene in human contracting skeletal muscle: influence of muscle glycogen contentThe FASEB Journal, 2001
- Production of interleukin‐6 in contracting human skeletal muscles can account for the exercise‐induced increase in plasma interleukin‐6The Journal of Physiology, 2000
- Regulation of Human Alveolar Macrophage Inflammatory Cytokine Production by Interleukin-10Clinical Immunology and Immunopathology, 1996